These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 1346333)

  • 1. Overexpression of glutathione S-transferase and elevation of thiol pools in a multidrug-resistant human colon cancer cell line.
    Chao CC; Huang YT; Ma CM; Chou WY; Lin-Chao S
    Mol Pharmacol; 1992 Jan; 41(1):69-75. PubMed ID: 1346333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of drug response in a cisplatin-resistant human lung cancer cell line.
    Fujiwara Y; Sugimoto Y; Kasahara K; Bungo M; Yamakido M; Tew KD; Saijo N
    Jpn J Cancer Res; 1990 May; 81(5):527-35. PubMed ID: 2116401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of lipopolysaccharide protection in tumor drug-induced macrophage damage.
    Song S; Zhang X; Cui L; Wang Y; Tian X; Wang K; Ji K
    Int J Biol Macromol; 2024 May; 266(Pt 2):131006. PubMed ID: 38522696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutathione Transferase (GST)-Activated Prodrugs.
    Ruzza P; Calderan A
    Pharmaceutics; 2013 Apr; 5(2):220-31. PubMed ID: 24300447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanisms of resveratrol as chemo and radiosensitizer in cancer.
    Cotino-Nájera S; Herrera LA; Domínguez-Gómez G; Díaz-Chávez J
    Front Pharmacol; 2023; 14():1287505. PubMed ID: 38026933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell plasticity modulation by flavonoids in resistant breast carcinoma targeting the nuclear factor kappa B signaling.
    Kubatka P; Koklesova L; Mazurakova A; Brockmueller A; Büsselberg D; Kello M; Shakibaei M
    Cancer Metastasis Rev; 2024 Mar; 43(1):87-113. PubMed ID: 37789138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity of Osteosarcoma Cells to Concentration-Dependent Bioactivities of Lipid Peroxidation Product 4-Hydroxynonenal Depend on Their Level of Differentiation.
    Sunjic SB; Gasparovic AC; Jaganjac M; Rechberger G; Meinitzer A; Grune T; Kohlwein SD; Mihaljevic B; Zarkovic N
    Cells; 2021 Jan; 10(2):. PubMed ID: 33572933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular Mechanisms Accounting for the Refractoriness of Colorectal Carcinoma to Pharmacological Treatment.
    Marin JJG; Macias RIR; Monte MJ; Herraez E; Peleteiro-Vigil A; Blas BS; Sanchon-Sanchez P; Temprano AG; Espinosa-Escudero RA; Lozano E; Briz O; Romero MR
    Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32933095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between micro- and nanosized copper oxide and water soluble copper chloride: interrelationship between intracellular copper concentrations, oxidative stress and DNA damage response in human lung cells.
    Strauch BM; Niemand RK; Winkelbeiner NL; Hartwig A
    Part Fibre Toxicol; 2017 Aug; 14(1):28. PubMed ID: 28764715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms of cisplatin resistance in cervical cancer.
    Zhu H; Luo H; Zhang W; Shen Z; Hu X; Zhu X
    Drug Des Devel Ther; 2016; 10():1885-95. PubMed ID: 27354763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring the Antioxidant Mediated Chemosensitization and ARE-Signaling in Triple Negative Breast Cancer Therapy.
    Foygel K; Sekar TV; Paulmurugan R
    PLoS One; 2015; 10(11):e0141913. PubMed ID: 26536456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenomics of cisplatin-induced ototoxicity.
    Mukherjea D; Rybak LP
    Pharmacogenomics; 2011 Jul; 12(7):1039-50. PubMed ID: 21787192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemosensitization of tumors by resveratrol.
    Gupta SC; Kannappan R; Reuter S; Kim JH; Aggarwal BB
    Ann N Y Acad Sci; 2011 Jan; 1215():150-60. PubMed ID: 21261654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proximal tubule cell hypothesis for cardiorenal syndrome in diabetes.
    Saito A; Kaseda R; Hosojima M; Sato H
    Int J Nephrol; 2010 Dec; 2011():957164. PubMed ID: 21197105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of the regulatory subunit of gamma-glutamylcysteine synthetase in HeLa cells increases gamma-glutamylcysteine synthetase activity and confers drug resistance.
    Tipnis SR; Blake DG; Shepherd AG; McLellan LI
    Biochem J; 1999 Feb; 337 ( Pt 3)(Pt 3):559-66. PubMed ID: 9895302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of steroid receptors, hsp27, and pS2 in a series of drug resistant human breast tumor cell lines derived following exposure to antitumor drugs or to fractionated X-irradiation.
    Whelan RD; Hill BT
    Breast Cancer Res Treat; 1993; 26(1):23-39. PubMed ID: 8400321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-variation of glutathione transferase expression and cytostatic drug resistance in HeLa cells: establishment of class Mu glutathione transferase M3-3 as the dominating isoenzyme.
    Hao XY; Widersten M; Ridderström M; Hellman U; Mannervik B
    Biochem J; 1994 Jan; 297 ( Pt 1)(Pt 1):59-67. PubMed ID: 8280111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutathione S-transferase activity in patients with cancer of the digestive tract.
    Severini G
    J Cancer Res Clin Oncol; 1993; 120(1-2):112-4. PubMed ID: 8270599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular models for multiple drug resistance in cancer.
    Clynes M
    In Vitro Cell Dev Biol; 1993 Mar; 29A(3 Pt 1):171-9. PubMed ID: 8096505
    [No Abstract]   [Full Text] [Related]  

  • 20. Expression of glutathione-S-transferases alpha and pi in gastric cancer: a correlation with cisplatin resistance.
    Kodera Y; Isobe K; Yamauchi M; Kondo K; Akiyama S; Ito K; Nakashima I; Takagi H
    Cancer Chemother Pharmacol; 1994; 34(3):203-8. PubMed ID: 8004752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.